Skip to content

To Study the effect of Herbal medicine (Draviyadi Capsules) in PreDiabetic stage.

An Open Label SingleArm Clinical Study to evaluate the efficacy OF Darviyadi Capsules in Pre- Diabetic Stage(Impaired Glucose Tolerance & Impaired Fasting Glucose)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020948
Enrollment
150
Registered
2019-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Darviyadi Capsules: Capsule contains aqueous extract derived from herbs 1) Daruharidra(Berberis aristata 2.5 gms 2) Devdaru (Cedrus deodara) 2.5 gms 3) Harad (Terminalia chebula)0.833

Sponsors

Dr Prajakta Tomar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between age of 30 years and 65 years. Patients having classical symptoms of Diabetes and Blood sugar elevation. Increased fasting Blood Sugar(FBS) more than 110 mg/dl Increased Post prandial blood sugar (PPBS) more than 140 mg/dl

Exclusion criteria

Exclusion criteria: Patients of age less than 30 years and more than 65 years. Patients of type 1 Diabetes Patients of DM dependent on insulin Diabetic patients with severe complications involving multiple organs and systems.

Design outcomes

Primary

MeasureTime frame
Fasting Blood Sugar upto 110mg/dl Post Prandial Blood Sugar up to 140mg/dl Urine Sugar fasting Nil Uriine Sugar PP NilTimepoint: 90 days

Secondary

MeasureTime frame
Fasting Blood sugar level upto 110 mg/dl Post Prandial Blood sugar level up to 140 mg/dlTimepoint: 90 days after stopping the treatment

Countries

India

Contacts

Public ContactDr Prajakta Tomar

MIAER

vdppt10@gmail.com8652566806

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026